This HTML5 document contains 199 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
n12http://dx.doi.org/10.1200/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33398808
rdf:type
wikibase:Item
schema:description
bilimsel makale 2011年论文 teaduslik artikkel artigo científico (publicado na 2011) مقالهٔ علمی article scientific 2011年論文 vitenskapelig artikkel სამეცნიერო სტატია מאמר מדעי 2011年论文 tudományos cikk 2011年論文 article scientifique (publié 2011) articol științific 2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած vedecký článok artykuł naukowy artikulong pang-agham επιστημονικό άρθρο 2011년 논문 bài báo khoa học 2011年論文 naučni članak article científic مقالة علمية vědecký článek wetenschappelijk artikel artigo científico (publicado na 2011) 2011年论文 2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված articolo scientifico научная статья mokslinis straipsnis 2011年论文 ২০১১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ tieteellinen artikkeli 2011 nî lūn-bûn videnskabelig artikel (udgivet 2011) vetenskaplig artikel artikull shkencor 2011年論文 artículu científicu espublizáu en 2011 мақолаи илмӣ 2011年论文 2011年の論文 บทความทางวิทยาศาสตร์ наукова стаття, опублікована в грудні 2011 سائنسی مضمون 2011年論文 scienca artikolo wissenschaftlicher Artikel scientific article artigo científico artículo científico publicado en 2011 научна статия vitskapeleg artikkel научни чланак научни чланак мақолаи илмӣ 2011年论文
p:P577
wds:Q33398808-07CFC8F6-D78A-410D-BC77-BE4265882BEC
wdt:P577
2011-12-19T00:00:00Z
p:P407
wds:Q33398808-49DFB167-DC7E-4C4F-B272-35EAB244E14A
wdt:P407
wd:Q1860
p:P2860
wds:Q33398808-9DDF8FB8-346D-4064-892B-A9C83A9225D4 wds:Q33398808-B1FD2B4A-BEB2-4805-807E-97E2CB67DEC2 wds:Q33398808-B322565A-8185-4EF6-B837-35991B76B3C2 wds:Q33398808-B503077B-390B-4046-8F30-849936FE5B47 wds:Q33398808-93709C5C-A11E-4E61-B8A8-A34E1BBF398A wds:Q33398808-9731B300-D72B-4306-A741-4091A6704474 wds:Q33398808-9DC42686-08F8-41D0-89A2-F071DA9FBE79 wds:Q33398808-C98D5B1C-30E4-4057-81C3-787747CC25E9 wds:Q33398808-D22B81AC-E54F-4F20-AD4C-139EE0086D04 wds:Q33398808-D2EF6BD1-216A-4C00-995C-BA185836D7A8 wds:Q33398808-D8CD5075-72A4-4452-8378-19CD956736B0 wds:Q33398808-FC3C64D2-F24B-4939-AE32-4C6D900066D9 wds:Q33398808-FCA32788-7B0C-4498-9E3C-F7AA89682C6D wds:Q33398808-F6B5ABD5-AC4D-4D2E-B336-FE696F93AF92 wds:Q33398808-FB710B4B-54C3-49C8-9731-635D15919E2B wds:Q33398808-0E2C4E9F-7E16-495F-9832-896AB73EB5ED wds:Q33398808-0E944553-C75A-42A3-B8F2-0D5AE49DDBA0 wds:Q33398808-029C5D53-C9C6-4D5B-BD3B-99E2A5A28097 wds:Q33398808-03671FB2-BAA7-4FF9-9EB3-EB5CB4EF7557 wds:Q33398808-0A7708C0-DCFD-4B0A-949F-30EACDFDC8C2 wds:Q33398808-1CC5014B-4145-4F1F-86BE-CA90F5181033 wds:Q33398808-14EDF3D2-10D5-409F-A0F8-C1EED45642DD wds:Q33398808-157EB912-9FA0-406A-BDA7-EC84895CD849 wds:Q33398808-17BBD895-5150-48D2-989D-433B21B5860D wds:Q33398808-39306FF3-7AA3-47B7-92AC-A9C9973B7113 wds:Q33398808-3031A7D0-28A9-41AD-97A9-5E17F96A4A0B wds:Q33398808-31ADAE69-F66A-43DF-B1A0-45EDFDE130CE wds:Q33398808-3900E6F6-3FA0-40D9-8C12-B1D2C1265A3F wds:Q33398808-7EC17E4B-231E-4C80-8243-255DB482D7A7 wds:Q33398808-8123AFB7-1D4D-4717-A356-E182B332C3B8 wds:Q33398808-56054FFA-4620-4A35-9235-F837235A164D wds:Q33398808-5A244879-AB56-4875-A4DB-8BD87D19A9FC wds:Q33398808-62F4C832-F2E0-4C9D-BD09-429D91BB570E
wdt:P2860
wd:Q33392920 wd:Q24616084 wd:Q53581386 wd:Q40497868 wd:Q41659044 wd:Q44059936 wd:Q28141442 wd:Q35250940 wd:Q29547595 wd:Q43763736 wd:Q42064781 wd:Q24293924 wd:Q54261266 wd:Q33381678 wd:Q40174205 wd:Q46330423 wd:Q33374664 wd:Q39736090 wd:Q24313505 wd:Q45046464 wd:Q29616727 wd:Q24337209 wd:Q46040273 wd:Q39684441 wd:Q36970689 wd:Q73893207 wd:Q36524763 wd:Q40007589 wd:Q39748438 wd:Q45916401 wd:Q28294137 wd:Q34382878 wd:Q28591736
p:P2093
wds:Q33398808-55FCB55D-A05D-46F2-A1EE-5F0E6F2ABF49 wds:Q33398808-7C944FB2-7F86-410B-8E41-68E5F838DEC6 wds:Q33398808-1F38D4CE-2A28-4090-AB1E-5F3C039FC76F wds:Q33398808-1A31A550-E061-46C1-84F1-6C35E1722329 wds:Q33398808-CCF21350-252E-44D5-904F-7474B9FC08B1 wds:Q33398808-E3FDD622-E4ED-4AEB-BF86-71A2FFD6ADCE wds:Q33398808-D8F78A6B-60DC-4CBC-8097-00797FF0A82D wds:Q33398808-DE791552-80C3-445E-B042-711D0C790328 wds:Q33398808-FAD3AB26-3BE8-4F78-ADA0-7EF489A539BD wds:Q33398808-F15B7224-902D-415B-BAC8-8A02BB8FAACB wds:Q33398808-BC81252E-5C13-4F42-A29C-F03B3545F30E wds:Q33398808-BF5A502F-A5F5-44EC-A897-FF6551D4A3F4 wds:Q33398808-BB882F42-BD88-4A5C-A979-466971B6659A wds:Q33398808-C487A4AA-148A-4745-9476-BCD1A879AA0C
wdt:P2093
Sari H Enschede Simon Z He John F Seymour Seong Lin Khaw Thomas J Kipps Jennifer R Brown Rod Humerickhouse Yue Cui Todd A Busman Hao Xiong Andrew P Krivoshik David C S Huang Dennis A Carney Evelyn M McKeegan
rdfs:label
Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease
skos:prefLabel
Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease
schema:name
Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease
p:P50
wds:Q33398808-B98CE76F-54B8-401B-BCE2-CB9005D67E9C wds:Q33398808-7435B4BF-5E24-4EFD-A31D-69BAE6DFEC47
wdt:P50
wd:Q64026278 wd:Q43445505
p:P1476
wds:Q33398808-11A6366C-A434-47FA-BF71-5CFD409C17CA
wdt:P1476
Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease
p:P304
wds:Q33398808-C37C4FB7-D071-4AB1-ADCC-F11AE9B9D692
wdt:P304
488-496
p:P31
wds:Q33398808-3BE0AD0D-E858-4A02-9A3B-57D017A7127A
wdt:P31
wd:Q13442814
p:P921
wds:Q33398808-259264EE-28BC-47C6-9648-A7920369C74F wds:Q33398808-3B747339-42F3-48F1-8CFC-7364B53DBE57 wds:Q33398808-EF0B23BD-3E31-4E59-8F1C-3DCECE585A46
wdt:P921
wd:Q1088156 wd:Q715347 wd:Q29496
p:P698
wds:Q33398808-9C37E748-8E7F-4389-B72B-9F7C570A1461
wdtn:P698
n7:22184378
wdt:P698
22184378
p:P1433
wds:Q33398808-0D3280D3-8C55-4DE4-83FB-2717730907AA
wdt:P1433
wd:Q400292
p:P433
wds:Q33398808-0B04B92B-6AC2-44C0-8017-337E2D928EAD
p:P478
wds:Q33398808-FEC59CBF-4E7C-42FF-B858-D28CA3D0D1C4
wdt:P433
5
wdt:P478
30
p:P356
wds:Q33398808-CCC2DFBB-BCBA-4624-9799-721DF3C2BF3A
wdtn:P356
n12:JCO.2011.34.7898
wdt:P356
10.1200/JCO.2011.34.7898
p:P932
wds:Q33398808-298EA5EA-5297-4725-A8DC-36DC7E3566A8
wdt:P932
4979082